Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roei D Mazor

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
BMC Medicine|December 2, 2014
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case seriesRoei D Mazor, Mirra Manevich-Mazor, Anat Kesler, et al.
Kidney International|November 14, 2022
Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosisThibaud Chazal, Francesco Pegoraro, Gaia Manari, et al.
Leukemia|November 17, 2021
MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axisRan Weissman, Eli L Diamond, Julien Haroche, et al.
Transplantation and Cellular Therapy|April 29, 2023
Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 SubstudyPaul Szabolcs, Roei D Mazor, Dima Yackoubov, et al.
Blood Advances|October 24, 2023
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasmsBenjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, et al.
Cancers|November 6, 2020
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester DiseaseRan Weissman, Eli L Diamond, Julien Haroche, et al.
Science Immunology|July 30, 2021
Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spilloversShelley Klompus, Sigal Leviatan, Thomas Vogl, et al.
Blood|March 19, 2020
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular eraGaurav Goyal, Mark L Heaney, Matthew Collin, et al.
Immunity|May 26, 2026
Tumor-draining lymph nodes in ovarian cancer lack germinal centers but harbor tumor-reactive memory B cells clonally linked to intra-tumoral B cellsNachum Nathan, Philipp Paparoditis, Avital Sarusi-Portuguez, et al.
Cell|March 19, 2022
Tumor-reactive antibodies evolve from non-binding and autoreactive precursorsRoei D Mazor, Nachum Nathan, Amit Gilboa, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
BMC Medicine|December 2, 2014
Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case seriesRoei D Mazor, Mirra Manevich-Mazor, Anat Kesler, et al.
Kidney International|November 14, 2022
Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosisThibaud Chazal, Francesco Pegoraro, Gaia Manari, et al.
Leukemia|November 17, 2021
MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axisRan Weissman, Eli L Diamond, Julien Haroche, et al.
Transplantation and Cellular Therapy|April 29, 2023
Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 SubstudyPaul Szabolcs, Roei D Mazor, Dima Yackoubov, et al.
Blood Advances|October 24, 2023
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasmsBenjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, et al.
Cancers|November 6, 2020
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester DiseaseRan Weissman, Eli L Diamond, Julien Haroche, et al.
Science Immunology|July 30, 2021
Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spilloversShelley Klompus, Sigal Leviatan, Thomas Vogl, et al.
Blood|March 19, 2020
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular eraGaurav Goyal, Mark L Heaney, Matthew Collin, et al.
Immunity|May 26, 2026
Tumor-draining lymph nodes in ovarian cancer lack germinal centers but harbor tumor-reactive memory B cells clonally linked to intra-tumoral B cellsNachum Nathan, Philipp Paparoditis, Avital Sarusi-Portuguez, et al.
Cell|March 19, 2022
Tumor-reactive antibodies evolve from non-binding and autoreactive precursorsRoei D Mazor, Nachum Nathan, Amit Gilboa, et al.
Pageof 3